|
OMIM |
Link |
Information gain |
01 |
|
PD
|
[NCBI]
|
0.00155216
|
|
|
geleophysic dysplasia
|
[NCBI]
|
0.000709234
|
|
|
AUTS9
|
[NCBI]
|
0.000650385
|
|
|
spatial visualization, aptitude for
|
[NCBI]
|
0.000605717
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.000600504
|
|
|
marden-walker syndrome
|
[NCBI]
|
0.000569748
|
|
|
coffin-siris syndrome
|
[NCBI]
|
0.000539666
|
|
|
FTD
|
[NCBI]
|
0.000509144
|
|
|
FRNS
|
[NCBI]
|
0.000414573
|
|
|
GTS
|
[NCBI]
|
0.000396285
|
|
|
RA
|
[NCBI]
|
0.000272994
|
|
|
PWS
|
[NCBI]
|
0.000249918
|
|
|
ADHD
|
[NCBI]
|
0.000213347
|
|
|
AD
|
[NCBI]
|
0.000182143
|
|
|
WBS
|
[NCBI]
|
0.000165377
|
|
|
CF
|
[NCBI]
|
0.000162821
|
|
|
HD
|
[NCBI]
|
0.000158725
|
|
|
SRS
|
[NCBI]
|
0.000156324
|
|
|
OOCH
|
[NCBI]
|
0.000120892
|
|
|
COMT
|
[NCBI]
|
0.000115709
|
|
|
GDNF
|
[NCBI]
|
0.000114875
|
|
|
MDD
|
[NCBI]
|
0.000104497
|
|
|
IS1
|
[NCBI]
|
9.96844e-05
|
|
|
SLE
|
[NCBI]
|
8.75888e-05
|
|
|
ACHE
|
[NCBI]
|
7.73294e-05
|
|
|
corpus callosum, partial agenesis of, x-linked
|
[NCBI]
|
7.59712e-05
|
|
|
hydroxyacyl-coa dehydrogenase ii deficiency
|
[NCBI]
|
7.09569e-05
|
|
|
megalencephaly-cutis marmorata telangiectatica congenita
|
[NCBI]
|
6.3664e-05
|
|
|
sturge-weber syndrome
|
[NCBI]
|
6.3664e-05
|
|
|
sulfocysteinuria
|
[NCBI]
|
6.3664e-05
|
|
|
c syndrome
|
[NCBI]
|
5.8377e-05
|
|
|
3-@methylglutaconic aciduria, type i
|
[NCBI]
|
5.8377e-05
|
|
|
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
[NCBI]
|
5.61942e-05
|
|
|
SCAR1
|
[NCBI]
|
5.42353e-05
|
|
|
FFI
|
[NCBI]
|
5.27586e-05
|
|
|
CDLS1
|
[NCBI]
|
5.27586e-05
|
|
|
congenital cataracts, facial dysmorphism, and neuropathy
|
[NCBI]
|
5.24594e-05
|
|
|
argininosuccinic aciduria
|
[NCBI]
|
5.08358e-05
|
|
|
hartnup disorder
|
[NCBI]
|
4.6668e-05
|
|
|
BDNF
|
[NCBI]
|
4.63104e-05
|
|
|
OPTB3
|
[NCBI]
|
4.5463e-05
|
|
|
weaver syndrome
|
[NCBI]
|
4.43317e-05
|
|
|
glucose transport defect, blood-brain barrier
|
[NCBI]
|
4.43317e-05
|
|
|
EAOH
|
[NCBI]
|
4.43317e-05
|
|
|
CLN2
|
[NCBI]
|
4.3266e-05
|
|
|
NHS
|
[NCBI]
|
4.13048e-05
|
|
|
EIG
|
[NCBI]
|
3.99462e-05
|
|
|
charge syndrome
|
[NCBI]
|
3.79248e-05
|
|
|
NEM3
|
[NCBI]
|
3.79248e-05
|
|
|
ALD
|
[NCBI]
|
3.63348e-05
|
|
|
ASTN
|
[NCBI]
|
3.58512e-05
|
|
|
APOE
|
[NCBI]
|
3.35588e-05
|
|
|
CHAT
|
[NCBI]
|
3.32319e-05
|
|
|
BCHE
|
[NCBI]
|
3.27908e-05
|
|
|
SLC6A3
|
[NCBI]
|
3.05433e-05
|
|
|
CPLX2
|
[NCBI]
|
2.92241e-05
|
|
|
FOSB
|
[NCBI]
|
2.70371e-05
|
|
|
DYT1
|
[NCBI]
|
2.69255e-05
|
|
|
GRID2
|
[NCBI]
|
2.4787e-05
|
|
|
GFAP
|
[NCBI]
|
2.43675e-05
|
|
|
MTM1
|
[NCBI]
|
2.39967e-05
|
|
|
RIMS1
|
[NCBI]
|
2.31638e-05
|
|
|
GNAQ
|
[NCBI]
|
2.31638e-05
|
|
|
GRM1
|
[NCBI]
|
2.31638e-05
|
|
|
TPH2
|
[NCBI]
|
2.27093e-05
|
|
|
DRD1
|
[NCBI]
|
2.27093e-05
|
|
|
NDN
|
[NCBI]
|
2.22876e-05
|
|
|
DVL1
|
[NCBI]
|
2.22876e-05
|
|
|
TH
|
[NCBI]
|
2.15438e-05
|
|
|
RTT
|
[NCBI]
|
2.12846e-05
|
|
|
RTN4
|
[NCBI]
|
2.11792e-05
|
|
|
phenylketonuria
|
[NCBI]
|
2.0737e-05
|
|
|
ADCYAP1
|
[NCBI]
|
2.04951e-05
|
|
|
EGF
|
[NCBI]
|
2.0482e-05
|
|
|
tay-sachs disease, ab variant
|
[NCBI]
|
2.02484e-05
|
|
|
NGFB
|
[NCBI]
|
1.9991e-05
|
|
|
SLC2A1
|
[NCBI]
|
1.99685e-05
|
|
|
ALS1
|
[NCBI]
|
1.96809e-05
|
|
|
SLC5A7
|
[NCBI]
|
1.94464e-05
|
|
|
SOD1
|
[NCBI]
|
1.86437e-05
|
|
|
SMA1
|
[NCBI]
|
1.80397e-05
|
|
|
VEGF
|
[NCBI]
|
1.74949e-05
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
1.68732e-05
|
|
|
SLC6A4
|
[NCBI]
|
1.65882e-05
|
|
|
ASPA
|
[NCBI]
|
1.65629e-05
|
|
|
glycogen storage disease i
|
[NCBI]
|
1.65629e-05
|
|
|
CREBBP
|
[NCBI]
|
1.5225e-05
|
|
|
DAO
|
[NCBI]
|
1.47678e-05
|
|
|
WHS
|
[NCBI]
|
1.45673e-05
|
|
|
CD
|
[NCBI]
|
1.45673e-05
|
|
|
GAL
|
[NCBI]
|
1.44008e-05
|
|
|
SCA1
|
[NCBI]
|
1.42347e-05
|
|
|
DRD2
|
[NCBI]
|
1.41455e-05
|
|
|
AS
|
[NCBI]
|
1.36245e-05
|
|
|
DNTT
|
[NCBI]
|
1.34981e-05
|
|
|
SMS
|
[NCBI]
|
1.20028e-05
|
|
|
RP
|
[NCBI]
|
1.18439e-05
|
|
|
CCK
|
[NCBI]
|
1.13897e-05
|
|
|
PTGS2
|
[NCBI]
|
1.10212e-05
|
|
|
ATM
|
[NCBI]
|
9.9777e-06
|
|
|
TNF
|
[NCBI]
|
9.48748e-06
|
|
|
MECP2
|
[NCBI]
|
8.78201e-06
|
|
|
PSEN1
|
[NCBI]
|
8.21418e-06
|
|
|
APP
|
[NCBI]
|
7.909e-06
|
|
|
SST
|
[NCBI]
|
7.35223e-06
|
|
|
PRL
|
[NCBI]
|
7.22424e-06
|
|
|
CDK5
|
[NCBI]
|
5.90746e-06
|
|
|
DMD
|
[NCBI]
|
5.72056e-06
|
|
|
CJD
|
[NCBI]
|
5.70124e-06
|
|
|
AVP
|
[NCBI]
|
4.18865e-06
|
|
|
EGFR
|
[NCBI]
|
3.8075e-06
|
|
|
PYY
|
[NCBI]
|
2.52308e-06
|
|
|
amyloidosis vi
|
[NCBI]
|
2.46151e-06
|
|
|
BWS
|
[NCBI]
|
1.54194e-06
|
|
|
MG
|
[NCBI]
|
1.23801e-06
|
|
|
GNRH1
|
[NCBI]
|
1.09064e-06
|
|
|
VIP
|
[NCBI]
|
9.56711e-07
|
|
|
SHH
|
[NCBI]
|
7.17153e-07
|
|
|
TG
|
[NCBI]
|
5.05741e-07
|
|
|
MPO
|
[NCBI]
|
4.4205e-07
|
|
|
NPY
|
[NCBI]
|
1.916e-07
|
|
|
PTH
|
[NCBI]
|
4.42128e-08
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
3.56447e-08
|
|